Switch, Don't Cycle: Interpreting the SELECT-SWITCH Trial and What It Means for RA Care

​

From Prescription to Possession: Understanding Medicare Access & Cap and Smooth

​

Upadacitinib in GCA: Interpreting the 2-Year SELECT-GCA Results

​

Inflammation Intersection: A Rheum-Gi Dialogue​

​

Spotting the Signs: Recognizing and Diagnosing Giant Cell Arteritis ​

​

Laying the Foundation: Historical Approaches to GCA Treatment 

​

Inside the Evidence: A Deep Dive into the SELECT-GCA Study

​

Expanding the Arsenal: JAK Inhibitors in the Evolving GCA Landscape

​

The Safety Conversation: Upadacitinib in the Treatment of GCA​​​​​​

​